Eli Lilly to buy psychedelic drug maker Atabekli for up to $3.8 billion in bet on depression therapy – Yahoo Finance
& more related News Here
- Eli Lilly to buy psychedelic drug maker Atabekli for up to $3.8 billion in bet on depression therapyyahoo finance
- Eli Lilly to buy psychedelics maker Atabekli for $2.8 billion as experimental treatments gain momentumcnbc
- Lilly to acquire Atibacel to advance treatments for treatment-resistant depression and other mental health conditionsPR Newswire
- Eli Lilly buys psychedelic biotech backed by Peter Thielfinancial Times
- Eli Lilly is nearing a deal to buy psychedelic drug maker Ataibekele, Bloomberg News reportsreuters